Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A new study found that alcohol-related liver and pancreas problems are increasing disproportionately among adolescents and ...

Pancreatic exocrine insufficiency (PEI) is a condition where the pancreas does not produce enough digestive enzymes, leading to difficulties in digesting food and absorbing nutrients. This ...

The pancreas, a gland situated behind the stomach, produces digestive enzymes that break down food and secretes hormones like insulin to regulate blood sugar. Pancreatic cancer is illustrated here ...

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion, but has been hard to obtain for the last year and ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

In the research published in BMC Surgery, fecal elastase-1 (FE-1) test emerged as the most frequently utilized diagnostic ...

Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even ... say they can detect changes in the enzyme that breaks down protein, protease.